GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bayer AG (BUE:BAYN) » Definitions » Cyclically Adjusted Price-to-FCF

Bayer AG (BUE:BAYN) Cyclically Adjusted Price-to-FCF : 5.35 (As of Jun. 05, 2024)


View and export this data going back to . Start your Free Trial

What is Bayer AG Cyclically Adjusted Price-to-FCF?

As of today (2024-06-05), Bayer AG's current share price is ARS3800.00. Bayer AG's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 was ARS709.74. Bayer AG's Cyclically Adjusted Price-to-FCF for today is 5.35.

The historical rank and industry rank for Bayer AG's Cyclically Adjusted Price-to-FCF or its related term are showing as below:

BUE:BAYN' s Cyclically Adjusted Price-to-FCF Range Over the Past 10 Years
Min: 4.78   Med: 13.68   Max: 33.49
Current: 5.33

During the past years, Bayer AG's highest Cyclically Adjusted Price-to-FCF was 33.49. The lowest was 4.78. And the median was 13.68.

BUE:BAYN's Cyclically Adjusted Price-to-FCF is ranked better than
95.65% of 322 companies
in the Drug Manufacturers industry
Industry Median: 32.255 vs BUE:BAYN: 5.33

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Bayer AG's adjusted free cash flow per share data for the three months ended in Mar. 2024 was ARS-2,419.856. Add all the adjusted free cash flow per share for the past 10 years together and divide 10 will get our Cyclically Adjusted FCF per Share, which is ARS709.74 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Bayer AG Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for Bayer AG's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bayer AG Cyclically Adjusted Price-to-FCF Chart

Bayer AG Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 13.47 9.52 9.29 8.77 6.12

Bayer AG Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 11.19 9.92 8.81 6.12 5.35

Competitive Comparison of Bayer AG's Cyclically Adjusted Price-to-FCF

For the Drug Manufacturers - General subindustry, Bayer AG's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bayer AG's Cyclically Adjusted Price-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Bayer AG's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Bayer AG's Cyclically Adjusted Price-to-FCF falls into.



Bayer AG Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

Bayer AG's Cyclically Adjusted Price-to-FCF for today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/ Cyclically Adjusted FCF per Share
=3800.00/709.74
=5.35

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bayer AG's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Bayer AG's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2024 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-2419.856/125.0381*125.0381
=-2,419.856

Current CPI (Mar. 2024) = 125.0381.

Bayer AG Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201406 14.281 99.543 17.939
201409 16.681 99.823 20.895
201412 16.487 99.543 20.710
201503 4.393 99.717 5.509
201506 16.657 100.417 20.741
201509 21.409 100.417 26.658
201512 16.371 99.717 20.528
201603 18.860 100.017 23.578
201606 26.460 100.717 32.850
201609 48.527 101.017 60.066
201612 34.698 101.217 42.864
201703 8.061 101.417 9.939
201706 38.446 102.117 47.076
201709 50.803 102.717 61.843
201712 34.475 102.617 42.008
201803 8.669 102.917 10.532
201806 56.668 104.017 68.120
201809 60.982 104.718 72.816
201812 80.576 104.217 96.674
201903 30.824 104.217 36.982
201906 58.727 105.718 69.460
201909 97.364 106.018 114.832
201912 147.242 105.818 173.987
202003 -43.284 105.718 -51.194
202006 143.529 106.618 168.326
202009 126.215 105.818 149.140
202012 -14.310 105.518 -16.957
202103 -337.732 107.518 -392.766
202106 174.727 108.486 201.386
202109 253.157 109.435 289.253
202112 221.391 110.384 250.783
202203 -129.395 113.968 -141.963
202206 201.204 115.760 217.330
202209 269.990 118.818 284.124
202212 314.003 119.345 328.982
202303 -864.623 122.402 -883.241
202306 -32.290 123.140 -32.788
202309 719.648 124.195 724.536
202312 1,847.718 123.773 1,866.605
202403 -2,419.856 125.038 -2,419.856

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Bayer AG  (BUE:BAYN) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


Bayer AG Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of Bayer AG's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Bayer AG (BUE:BAYN) Business Description

Industry
Address
Kaiser-Wilhelm-Allee 1, Leverkusen, NW, DEU, 51368
Bayer is a German healthcare and agriculture conglomerate. Healthcare provides close to half of the company's sales and includes pharmaceutical drugs as well as vitamins and other consumer healthcare products. The firm also has a crop science business that includes seeds, pesticides, herbicides, and fungicides, which was expanded through the acquisition of Monsanto.

Bayer AG (BUE:BAYN) Headlines